Richard R. DeLuca, EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. (MRK), sold 37,685 shares at $120.92 ($4.6M) on 2026-02-06, disclosed to the SEC on 2026-02-06.
Open-market sale of $4.6M MRK by EVP&Pres, Merck Animal Heallth. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MRK | SELL | 2023-11-09 | $9.2M | — | Filing → |
| MRK | SELL | 2023-05-02 | $25.1M | — | Filing → |
| MRK | SELL | 2022-11-01 | $33.0M | — | Filing → |